Literature DB >> 29024462

Attitudes to personality disorder of staff working in high-security and medium-security hospitals.

R Beryl1, B Völlm2.   

Abstract

The discourse surrounding personality disorder is largely negative, and the diagnosis is considered to be associated with a degree of stigma. This study aimed to investigate staff attitudes towards personality disorder in high-security and medium-security forensic-psychiatric hospitals in the UK. The Attitude to Personality Disorder Questionnaire was completed by 132 participants who were all current employees with clinical roles. Staff attitudes to personality disorder in the current study were significantly less positive than in comparable studies in similar settings. Having completed staff training surrounding personality disorder and being from a non-nursing professional background were the best predictors of positive attitudes to personality disorder. The findings of this study offer support to the pursuit of improving access to training in personality disorder for those working with this clinical presentation.
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 29024462     DOI: 10.1002/pmh.1396

Source DB:  PubMed          Journal:  Personal Ment Health        ISSN: 1932-8621


  3 in total

1.  Explaining the willingness of clinicians to work with patients with antisocial personality disorder using the theory of planned behaviour and emotional reactions.

Authors:  Arno van Dam; Madeleine Rijckmans; Louisa van den Bosch
Journal:  Clin Psychol Psychother       Date:  2021-08-30

2.  The experience of long stay in high and medium secure psychiatric hospitals in England: qualitative study of the patient perspective.

Authors:  Jessica Holley; Tim Weaver; Birgit Völlm
Journal:  Int J Ment Health Syst       Date:  2020-03-30

3.  A Comparison of English and Dutch Long-Stay Patients in Forensic Psychiatric Care.

Authors:  Dhanuja Senn; Erik Bulten; Jack Tomlin; Birgit Völlm
Journal:  Front Psychiatry       Date:  2020-11-30       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.